Out of these 12 funds, 11 have been in the market for more than 25 years. They have delivered consistent double-digit returns over decades, highlighting the benefits of long-term investing. Despite market fluctuations and multiple benchmark changes, these schemes demonstrate strong resilience and growth potential for disciplined investors.
Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challenges
Pankaj Pandey shares insights on Indian sectors facing US tariffs. He sees limited impact on pharma growth but potential benefits for Jubilant Pharma and Piramal